Loading clinical trials...
Loading clinical trials...
To assess the safety and efficacy of SU011248 in patients with metastatic, refractory renal cell carcinoma
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Pfizer
NCT04895709 · Cervical Cancer, Gastric/Gastroesophageal Junction Adenocarcinoma, and more
NCT07227415 · Carcinoma, Renal Cell, Advanced Renal Cell Carcinoma, and more
NCT05127824 · Carcinoma, Renal Cell
NCT05865730 · Carcinoma, Renal Cell, Carcinoma, Non-Small-Cell Lung
NCT03091192 · Carcinoma, Carcinoma, Renal Cell, and more
Pfizer Investigational Site
Duarte, California
Pfizer Investigational Site
Pasadena, California
Pfizer Investigational Site
San Francisco, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions